An unusual case of paradoxical enlargement of lymph nodes during treatment of tuberculous lymphadenitis in immunocompetent patient and literature review

American Journal of Case Reports

Volumn 14, Issue , 2013, Pages 201-204

  Singh, Anil ^a   HabiburRahman, ^a   Kumar, Viki ^a   Anila, Fnu ^a  

^a QUEENS HOSPITAL CENTER   (United States)

Author keywords

Highly active anti retroviral therapy (HAART); Isoniazid; Kikuchi's disease (KD); Paradoxical reaction (PR); Pyrazinamide and ethambutol (RIPE); Rifampin; Tuberculosis (TB); Tuberculosis lymphadenitis (TL)

Indexed keywords

ETHAMBUTOL; ISONIAZID; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BANGLADESHI; CASE REPORT; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG DOSE REDUCTION; ETHNIC GROUP; FEMALE; FEVER; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MEDICAL HISTORY; PARADOXICAL DRUG REACTION; RADIODIAGNOSIS; SUBCUTANEOUS TISSUE; TREATMENT OUTCOME; TUBERCULOUS LYMPHADENITIS; WEIGHT REDUCTION;

EID: 84879174789     PISSN: None     EISSN: 19415923     Source Type: Journal    
DOI: 10.12659/AJCR.889013     Document Type: Article

References (15)

1. Carvalho AC, De iaco G, Saleri N et al: Paradoxical reaction during tuberculosis treatment in HIV-seronegative patients. Clin Infect Dis, 2006; 42(6): 893-895
2. Breen RA, Smith CJ, Bettinson H et al: Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax, 2004; 59(8): 704-707
3. Campbell IA, Dyson AJ: Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle, 1977; 58(4): 171-179
4. Rooney JJ, Crocco JA, Kramer S, Lyons HA: Further observations on tuberculin reactions in active tuberculosis. Am J Med, 1976; 60(4): 517-522
5. Cho OH, Park KH, Kim T et al: Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect, 2009; 59(1): 56-61
6. Hawkey CR, Yap T, Pereira J et al: Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis, 2005; 40(9): 1368-1371
7. Polesky A, Grove W, Bhatia G: Peripheral tuberculous lymphadenitis: epidemiology, diagnosis, treatment, and outcome. Medicine (Baltimore), 2005; 84(6): 350-62
8. Lee KC, Tami TA, Lalwani AK, Schecter G: Contemporary management of cervical tuberculosis. Laryngoscope, 1992; 102(1): 60-64
9. Lee S, Yoo JH, Lee SW: Kikuchi disease: differentiation from tuberculous lymphadenitis based on patterns of nodal necrosis on CT. AJNR Am J Neuroradiol, 2012; 33(1): 135-140
10. Blackmore TK, Manning L, Taylor WJ, Wallis RS: Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes. Clin Infect Dis, 2008; 47(10): e83-e85
11. Dooley DP, Carpenter JL, Rademacher S: Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis, 1997; 25(4): 872-887
12. Nemir RL, Cardona J, Lacoius A, David M: Prednisone therapy as an adjunct in the treatment of lymph node-bronchial tuberculosis in childhood. a double- blind study. Am Rev Respir Dis, 1963; 88: 189-198
13. Shelburne SA, Hamill RJ, Rodriguez-Barradas MC et al: Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore), 2002; 81(3): 213-227
14. Shelburne SA, Montes M, Hamill RJ: Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother, 2006; 57(2): 167-170
15. Meintjes G, Lawn SD, Scano F et al: Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resourcelimited settings. Lancet Infect Dis, 2008; 8(8): 516-523